DEA Archived Press Releases

Press Releases before January 20, 2025
315 Results - Showing 81 to 90
PRESS RELEASE

New Hampshire Doctor Indicted for Unlawfully Distributing Opioids and Benzodiazepines

CONCORD, N.H. – A doctor practicing in the north country of New Hampshire was indicted in connection with his unlawful distribution of opioids and benzodiazepines, U.S. Attorney Jane E. Young announces. Robert G. Soucy Jr., D.O., 70, of Columbia, New Hampshire, was indicted on 12 counts of distribution of controlled...
PRESS RELEASE

Pharmacist Convicted for Conspiring to Unlawfully Dispense Over 100,000 Opioid Pills

Houston, TX. – A federal jury in Houston convicted a Texas pharmacist yesterday for her role in a pill-mill pharmacy that unlawfully dispensed over 100,000 opioid pills in exchange for cash. According to court documents and evidence presented at trial, from January 2014 to January 2018, Deanna Winfield-Gates, 54, of...
PRESS RELEASE

Pharmacy Agrees to Pay $250,000 for Improperly Distributing Prescriptions

KANSAS CITY, Kan. - A Kansas City, Kansas, company entered into a civil settlement agreement with the federal government to pay $250,000 to resolve allegations that a retail pharmacy it owns violated the civil provisions of the Controlled Substances Act. Four B. Corporation, doing business as Balls Food Stores, owns...
PRESS RELEASE

Illinois Man Sentenced to 30 Months for Theft of Medical Products and Possession of a Controlled Substance with Intent to Distribute

SPRINGFIELD, Ill. – Todd C. Smith, Assistant Special Agent in Charge at U.S. Drug Enforcement Administration Chicago Field Division, and U.S. Attorney Gregory K. Harris for the Central District of Illinois announced that Issac Jackson, 29, of Le Roy, Illinois, was sentenced on Sept. 7, 2023, to 30 months in...
PRESS RELEASE

Health Care Company and Cheshire Pharmacy Pay $500K to Resolve Controlled Substances Act Allegations

CHESHIRE, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, Brian D. Boyle, Special Agent in Charge of the Drug Enforcement Administration for New England, announced that Clarest, LLC, doing business as Clarest Health, ProCare LTC New England LTC, and ProCare LTC Pharmacy of Connecticut LLC...
PRESS RELEASE

Former Auburn Physician Pays $135,000 and Forfeits DEA Registration, for Overprescribing Controlled Substances

SYRACUSE, NEW YORK – Dr. Jang Boo Chi, formerly a physician in Auburn, and his medical practice, Jang Boo Chi M.D. P.C., have agreed to pay the United States $135,000 in civil penalties for overprescribing opioids and other controlled substances in dangerous combinations. United States Attorney Carla B. Freedman, and...
PRESS RELEASE

Austin Pharmacy to Pay $200,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

AUSTIN, Texas – People’s Pharmacy Inc. has agreed to pay $200,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act (CSA). People’s Pharmacy Inc., doing business as Peoples Rx, operates five retail pharmacies and one compounding laboratory in the Austin area. During a routine...
PRESS RELEASE

Nurse Practitioner Pleads Guilty to Unlawful Drug Distribution

ALBANY, NEW YORK – Danielle Simonson, age 51, of Fort Ann, New York, pled guilty today to distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. The announcement was made by United States Attorney Carla B. Freedman; Special Agent in Charge Frank A. Tarentino...
PRESS RELEASE

CA Attorney General Bonta Announces Arrest of Santa Clara Doctor for Illegal Opioid Prescription Scheme

SANTA CLARA, Calif. — California Attorney General Rob Bonta today announced the arrest of and filing of charges against Dr. Arash Padidar, a Santa Clara County doctor accused of illegally prescribing opioids to patients. The arrest and charges are the result of an investigation into an alleged two-years-long illegal prescription...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...